Navigation Links
RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute
Date:1/31/2013

NORCROSS, Ga., Jan. 31, 2013 /PRNewswire/ -- RayBiotech, Inc. announced today that it has executed a master services agreement with Banner Sun Health Research Institute (BSHRI) of Sun City, Arizona.  Under the terms of the agreement, RayBiotech will provide priority services for the biochemical analysis of disease markers in biological samples.  A particular focus of the pact will be on the characterization of key biomarkers for the study of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.  Financial terms were not disclosed.

RayBiotech's President, Chief Operating Officer and Co-Founder, Rani Huang stated, "We are excited about providing biomarker analysis services to BSHRI researchers.  Banner Sun Health Research Institute is a unique world-class research organization that has outstanding tissue depository program, clinical center that conducts a large number of clinical trials, and research scientists who are dedicated to translational research in neurodegenerative and cardiovascular disorders.  We believe that the collaboration will yield promising new opportunities facilitating early diagnosis of these devastating diseases."

BSHRI research scientists are involved in biomarker discovery research in both Alzheimer's and Parkinson's diseases.  Senior Scientist Dr. LihFen Lue said, "As we continue to strive towards a better understanding of the molecular mechanisms at early stage of these neurodegenerative diseases, we also recognize the importance of identifying proteins present in the biofluid that could be used as potential disease biomarkers. Fortunately, we have more cutting-edge tools these days to do this crucial research.  Raybiotech Quantibody® array is one of these very useful tools."

RayBiotech provides a valuable biochemical platform to assess both the identity and quantity of these markers in a comprehensive high-throughput format.  The master service agreement with BSHRI is an important step demonstrating the dedication to provide outstanding products and service from RayBiotech to the scientific community.

About RayBiotech, Inc.

In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets.  RayBiotech products are featured in thousands of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in metropolitan Atlanta.

About Banner Sun Health Research Institute

Founded in 1986 as a private, nonprofit biomedical research center, Banner Sun Health Research Institute (BSHRI) conduct basic and translational research, clinical research, prevention and education programs specialized in the study of normal aging and certain age-related diseases, including Alzheimer's, Parkinson's  and Parkinson's diseases, and cardiovascular disease.  The Institute is the applicant organization for the Arizona Alzheimer's Disease Center, a leading statewide research program that has been recognized and supported by the National Institutes of Health (NIH). Research at the BSHRI is funded by grants from the NIH, the Michael Fox Foundation, the Alzheimer's Association, and private donations.  The Institute maintains collaborations with many nationally- and internationally-recognized institutions and provides highest quality of autopsy tissues to research community through a very successful Whole Body and Brain Tissue Depository Program.  The clinical center at the BSHRI also participates in many important clinical trials and biomarker discovery research.  

For More Information:

Rob Burgess , PhD
Director, Business Development
RayBiotech, Inc.
Phone: 770-729-2992
Email: rob@raybiotech.com


'/>"/>
SOURCE RayBiotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Stanford and MIT scientists win Perl-UNC Neuroscience prize
2. 6th Annual Canadian Neuroscience Meeting, Vancouver, May 20-23, 2012
3. UCSF pair win Gruber Foundation Neuroscience prize
4. Wiring bats for neuroscience research
5. Media registration opens for Neuroscience 2012, worlds largest brain science meeting
6. Neuroscience: The extraordinary ease of ordinal series
7. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
8. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
9. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
10. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
11. New biomarker for common lung cancer predicts responses to chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed ... received the prestigious international IAIR Award for the most innovative high security ... ... Maldives Immigration Controller General, ... picture on the right) have received the IAIR award for the "Most ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
Breaking Biology News(10 mins):
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick Innovative Technology Center, Inc. ... technology-based businesses, recently earned a $77,518 grant from the Rural Maryland Council (RMC) ... FITCI is Frederick’s first incubator. A non-profit corporation, FITCI is a public-private partnership ...
(Date:4/20/2017)... Lilly and Company (NYSE: LLY ) will ... of migraine at the American Academy of Neurology (AAN) ... in Boston . ... and patient outcomes data for galcanezumab in patients with ... migraine headache days among patients with episodic migraine. Lilly ...
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a ... over 20 years of experience in the learning technologies industry, Mastin joins NetDimensions from ... Learning Technologies Group plc (LTG). At LEO, Mastin served as SVP of the North ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader in ... today that they were named one of the 2017 Top 10 eClinical Trial ... in the pharmaceutical industry. , “We take pride in honoring Parallel6 as one of ...
Breaking Biology Technology: